Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

Etanercept Submitted to FDA for Approval to Treat Pediatric Plaque Psoriasis; Boehringer Ingelheim & AbbVie to Collaborate; Low Doses of Gerilimzumab Promising for RA

Michele B. Kaufman, PharmD, BCGP  |  April 13, 2016

The FDA has received an application to expand the use of etanercept to treat plaque psoriasis in pediatric patients. Boehringer Ingelheim and AbbVie have announced a collaborative partnership to develop treatments for multiple autoimmune diseases. And gerilimzumab may prove safe and effective for treating inflammatory diseases at very low doses…

Filed under:Biologics/DMARDsDrug Updates Tagged with:etanerceptgerilimzumabInflammatory Diseasemonoclonal antibodyplaque psoriasisRheumatoid Arthritis (RA)

Wise Transitions: Improving Pediatric–Adult Care

Arthritis & Rheumatology  |  March 29, 2016

Transitions in medical care can be high-risk periods due to the loss of continuity in care and worsening of medical conditions. Approximately one-quarter of the estimated 18 million adolescents aged 18–21 years in the U.S. have chronic conditions, including rheumatic diseases. Interventions in rheumatology practice can improve transition processes. Transition-readiness assessment tools and transition-satisfaction scales are available for use in rheumatology transition processes…

Filed under:ConditionsPediatric ConditionsPractice SupportResearch Rheum Tagged with:agingArthritis & Rheumatologychronic conditionPediatricPediatric RheumatologyResearchrheumatologyTransitions

The Genetic Factor: Research Examines Genetic Heritability for Pediatric Autoimmune Diseases

Richard Quinn  |  February 5, 2016

Recent research has helped further define genetic heritability for pediatric autoimmune diseases. In an interview, Dr. Hakon Hakanarson discusses how understanding common genetic factors can help develop risk prediction and treatments for such diseases as juvenile idiopathic arthritis, lupus and celiac disease…

Filed under:Conditions Tagged with:Autoimmune diseaseGenetic researchgenetic riskgenomicsPediatric RheumatologyPediatrics

Mycophenolate Sodium Effective for Chronic Noninfectious Pediatric Uveitis

Reuters Staff  |  December 1, 2015

NEW YORK (Reuters Health)—Mycophenolate sodium (MPS) is effective for treating children with chronic noninfectious uveitis, researchers from Germany report. “Mycophenolate sodium could be used as a preferred steroid-sparing agent in children with chronic noninfectious intermediate uveitis,” Dr. Deshka Doycheva, from the University of Tuebingen, Germany, told Reuters Health by email. MPS is an enteric-coated formulation…

Filed under:ConditionsOther Rheumatic ConditionsPediatric Conditions Tagged with:ChildrengastrointestinalMycophenolate SodiumPediatricUveitis

Celiac Disease in Pediatric Patients

Richard Quinn  |  October 21, 2015

A retrospective study shows that some patients presenting for pediatric rheumatology evaluation test positive for celiac disease—some without showing any gastrointestinal manifestations. Treatment includes a gluten-free diet…

Filed under:ConditionsPractice Support Tagged with:celiac diseasegastrointestinalPediatric RheumatologyPractice Management

Screen Type 1 Diabetes & Pediatric Rheumatology Patients for Celiac Disease

Reuters Staff  |  June 20, 2015

NEW YORK (Reuters Health)—Screening for celiac disease (CD) is important in patients newly diagnosed with type 1 diabetes (T1D) and in children presenting for rheumatology evaluation, according to a pair of new reports. In a systematic review, online June 15 in Pediatrics, Australian researchers found most cases of CD are diagnosed within five years of…

Filed under:Conditions Tagged with:celiac diseasediabetespatient carePediatric Rheumatology

Pediatric to Adult Care Transition Challenging for Patients with JIA

Pediatric to Adult Care Transition Challenging for Patients with JIA

Lynn R. Spiegel, MD, FRCPC  |  May 15, 2015

Dr. Sheffield is an adult rheumatologist who received the following referral request from a family doctor: “Please see this 22-year-old male with a history of juvenile arthritis for ongoing care. I have only seen him once, and have no previous medical records.” Dr. Sheffield meets with Paul, who reports that he has had arthritis since…

Filed under:ConditionsOther Rheumatic ConditionsPediatric Conditions Tagged with:Juvenile idiopathic arthritispatient carePediatric

Pediatric Rheumatologist Wins 2014 Award for Excellence in Clinical Medicine

Staff  |  December 1, 2014

The ACR member Dr. Marilyn G. Punaro is first pediatric rheumatologist to earn the Patricia & William L. Watson Jr., MD, award

Filed under:From the CollegeProfessional TopicsProfiles Tagged with:AC&RAmerican College of Rheumatology (ACR)AwardsClinicalmedicinePediatricsProfilerheumatologistWatson

Pediatric Chronic Pain Eased by Early Intervention, Parental Involvement

Mary Beth Nierengarten  |  November 2, 2014

Comfort Ability program provides psychological strategies to help children self-manage symptoms

Filed under:AnalgesicsConditionsDrug UpdatesPain SyndromesPediatric ConditionsPractice SupportQuality Assurance/Improvement Tagged with:Chronic painNierengartenPainpatient carePediatricpsychologicalTreatment

2014 Pediatric Rheumatology Symposium Scheduled April 3–6 in Orlando, Florida

Staff  |  February 1, 2014

Conference to feature practice management tips and latest findings in clinical, translational, and basic research on treating rheumatic diseases in children

Filed under:Career DevelopmentEducation & TrainingFrom the CollegeProfessional TopicsResearch Rheum Tagged with:education and trainingpatient carePediatric Rheumatology SymposiumPediatricsResearchRheumatic Diseaserheumatologist

  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 109
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences